Tirzepatide is a next-generation peptide that combines the action of two key hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These dual mechanisms work together to regulate appetite, improve insulin sensitivity, and enhance metabolism. Initially developed to manage type 2 diabetes, Tirzepatide has demonstrated remarkable results in promoting significant and sustained weight loss, making it a powerful tool in our LeanLOVE Medical Weight Loss Program.

Tirzepatide is a dual-action medication that targets both GIP and GLP-1 receptors, offering enhanced metabolic benefits compared to Semaglutide, which focuses solely on GLP-1. This dual mechanism allows Tirzepatide to provide greater support for weight loss, blood sugar regulation, and inflammation reduction. Additionally, Tirzepatide is administered as a weekly injection, while Semaglutide is available as a daily sublingual solution. Your provider will help determine which medication is best suited to your health goals and lifestyle.

Semaglutide is an FDA-approved medication. When used under the guidance of a healthcare professional, Semaglutide is considered safe.

Yes, Semaglutide is also used for weight management in individuals who may not have diabetes, particularly when lifestyle changes alone have not been effective.

Most people would prefer not to self-inject, and Semaglutide oral tablets are poorly absorbed (less than 1% per the labeling for Rybelsus®). For these reasons, B12 LOVE chose to offer a patent-pending compounded formulation of Semaglutide for sublingual administration.

Common side effects include headache/dizziness, nausea, vomiting, diarrhea, stomach pain, and constipation. These are usually mild and tend to decrease over time.

Currently, we do not accept insurance for this program, and B12 LOVE is not affiliated with any insurance companies. Payment is required at the time of the service.

Semaglutide can interact with other medications. It’s important to inform your healthcare provider about your medications to avoid potential interactions.

Typically, Semaglutide is approved for use in adults over 18. Consult your B12 LOVE healthcare provider for advice tailored to your specific situation.

Individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) should not take Semaglutide. Your B12 LOVE healthcare provider can provide more information on other contraindications. Also, women who are pregnant or planning to become pregnant should not take this medication.

The duration of the program can vary based on individual goals and response to treatment. Discussing your treatment plan and expected duration with your B12 LOVE healthcare provider is best. We highly recommend a commitment to a 6-month program for best results.

While individual results may vary, many participants begin to see weight loss within the first two months of starting treatment. For optimal outcomes, consistent use of the program combined with lifestyle changes is often necessary.

Our Semaglutide is sourced from a reputable, accredited compounding pharmacy, ensuring high quality and safety standards. The raw materials are sourced in the US and tested for quality assurance.

While you might come across lower-priced options online, exercising caution is crucial. Significantly lower prices could be a red flag for counterfeit or inferior-quality medications. It’s vital to ensure you obtain your medications from trusted and reputable sources to guarantee safety and efficacy. Our program pricing is designed to be transparent and includes all costs associated with your personalized treatment plan.

Unfortunately no, we do not offer payment plans or financing for this program.